Skip to main content

Advertisement

SpringerLink
Log in

Silencing YKL-40 gene can inhibit inflammatory factor expression and affects the effect of THP-1 cells on endometrial cancer

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

To investigate the effect of silencing the YKL-40 gene on the expression of inflammatory factors and the effect of silencing the YKL-40 gene of THP-1 cells on endometrial cancer.

Methods

We used a siRNA targeting a sequence in YKL-40 (si-YKL-40) to transfect HEC-1A and THP-1 cells. Quantitative real-time polymerase chain reaction assay was performed to investigate the mRNA levels of YKL-40, IL-8 and MMP-9 in HEC-1A and THP-1 cells. Migration, and invasion assays were performed to identify the effects of co-culture with THP-1 cells that silenced YKL-40 gene on the migration and invasion capacity of HEC-1A cells. Tube formation ability were detected by Matrigel-based angiogenesis assay.

Results

We successfully transfected HEC-1A and THP-1 cells with lentivirus to silence the YKL-40 gene. Compared with the blank control group and NC group, the expression of YKL-40, IL-8 and MMP-9 which were examined by qRT-PCR in YKL-40-siRNA group was significantly reduced in the two cell lines; after co-cultured with the supernatant of transfected THP-1 cells, the migration and invasion ability of HEC-1A cells in YKL-40-siRNA group was significantly reduced; the number of tubes in the YKL-40-siRNA group was significantly reduced, the spacing between the tubes was significantly increased, and the structure of tubes was incomplete.

Conclusion

Silencing the YKL-40 gene in THP-1 cells can inhibit the expression of inflammatory factors, the invasion and migration of human endometrial cancer cells and the capacity of vitro angiogenic. And YKL-40 gene as a marker of inflammation may be an effective therapeutic target for endometrial cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Borghi C, Indraccolo U, Scutiero G, Iannone P, Martinello R, Greco P, Greco F, Nappi L (2018) Biomolecular basis related to inflammation in the pathogenesis of endometrial cancer. Eur Rev Med Pharmacol Sci 22(19):6294–6299. https://doi.org/10.26355/eurrev_201810_16038

    Article  CAS  PubMed  Google Scholar 

  2. Uygur B, Leikina E, Melikov K, Villasmil R, Verma SK, Vary CPH, Chernomordik LV (2019) Interactions with muscle cells boost fusion, stemness, and drug resistance of prostate cancer cells. Mol Cancer Res 17(3):806–820. https://doi.org/10.1158/1541-7786.MCR-18-0500

    Article  CAS  PubMed  Google Scholar 

  3. Chatterjee S, Chatterjee A, Jana S, Roy H, Nargis N, Bhattacharyya A (2018) Breast tumor-associated exosomes mediate loss of antitumor immune response by arresting cytotoxic T cell functions in the tumor microenvironment. Ann Oncol 29(Suppl 9):ix8–ix9. https://doi.org/10.1093/annonc/mdy427.003

    Article  Google Scholar 

  4. Park W, Lopes G (2019) Perspectives: neutrophil-to-lymphocyte ratio as a potential biomarker in immune checkpoint inhibitor for non-small-cell lung cancer. Clin Lung Cancer 20(3):143–147. https://doi.org/10.1016/j.cllc.2018.12.003

    Article  CAS  PubMed  Google Scholar 

  5. Winkler I, Bitter C, Winkler S, Weichenhan D, Thavamani A, Hengstler JG, Borkham-Kamphorst E, Kohlbacher O, Plass C, Geffers R, Weiskirchen R, Nordheim A (2020) Identification of Ppargamma-modulated miRNA hubs that target the fibrotic tumor microenvironment. Proc Natl Acad Sci USA 117(1):454–463. https://doi.org/10.1073/pnas.1909145117

    Article  CAS  PubMed  Google Scholar 

  6. Jiang XF, Tang QL, Li HG, Shen XM, Luo X, Wang XY, Lin ZQ (2013) Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma. J Obstet Gynaecol Res 39(4):855–863. https://doi.org/10.1111/j.1447-0756.2012.02036.x

    Article  CAS  PubMed  Google Scholar 

  7. Chen XJ, Deng YR, Wang ZC, Wei WF, Zhou CF, Zhang YM, Yan RM, Liang LJ, Zhong M, Liang L, Wu S, Wang W (2019) Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment. Cell Death Dis 10(7):508. https://doi.org/10.1038/s41419-019-1748-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T, Lu J, Liu J (2013) Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat 12(3):259–267. https://doi.org/10.7785/tcrt.2012.500312

    Article  CAS  PubMed  Google Scholar 

  9. Li LY, Yin KM, Bai YH, Zhang ZG, Di W, Zhang S (2019) CTHRC1 promotes M2-like macrophage recruitment and myometrial invasion in endometrial carcinoma by integrin-Akt signaling pathway. Clin Exp Metastasis 36(4):351–363. https://doi.org/10.1007/s10585-019-09971-4

    Article  CAS  PubMed  Google Scholar 

  10. Gu S, Ni T, Wang J, Liu Y, Fan Q, Wang Y, Huang T, Chu Y, Sun X, Wang Y (2018) CD47 blockade inhibits tumor progression through promoting phagocytosis of tumor cells by M2 polarized macrophages in endometrial cancer. J Immunol Res 2018:6156757. https://doi.org/10.1155/2018/6156757

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Fan JT, Li MJ, Shen P, Xu H, Li DH, Yan HQ (2014) Serum and tissue level of YKL-40 in endometrial cancer. Eur J Gynaecol Oncol 35(3):304–308

    CAS  PubMed  Google Scholar 

  12. Torre LA, Islami F, Siegel RL, Ward EM, Jemal A (2017) Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev 26(4):444–457. https://doi.org/10.1158/1055-9965.EPI-16-0858

    Article  PubMed  Google Scholar 

  13. Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA (2014) Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014:149185. https://doi.org/10.1155/2014/149185

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zeng Y, Yao X, Liu X, He X, Li L, Liu X, Yan Z, Wu J, Fu BM (2019) Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis. J Extracell Vesicles 8(1):1629865. https://doi.org/10.1080/20013078.2019.1629865

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kubler K, Ayub TH, Weber SK, Zivanovic O, Abramian A, Keyver-Paik MD, Mallmann MR, Kaiser C, Serce NB, Kuhn W, Rudlowski C (2014) Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma. Gynecol Oncol 135(2):176–183. https://doi.org/10.1016/j.ygyno.2014.08.028

    Article  CAS  PubMed  Google Scholar 

  16. Ring KL, Yemelyanova AV, Soliman PT, Frumovitz MM, Jazaeri AA (2017) Potential immunotherapy targets in recurrent cervical cancer. Gynecol Oncol 145(3):462–468. https://doi.org/10.1016/j.ygyno.2017.02.027

    Article  CAS  PubMed  Google Scholar 

  17. Hashimoto I, Kodama J, Seki N, Hongo A, Miyagi Y, Yoshinouchi M, Kudo T (2000) Macrophage infiltration and angiogenesis in endometrial cancer. Anticancer Res 20(6C):4853–4856

    CAS  PubMed  Google Scholar 

  18. Jiang S, Yang Y, Fang M, Li X, Yuan X, Yuan J (2016) Co-evolution of tumor-associated macrophages and tumor neo-vessels during cervical cancer invasion. Oncol Lett 12(4):2625–2631. https://doi.org/10.3892/ol.2016.5014

    Article  PubMed  PubMed Central  Google Scholar 

  19. Szewczyk G, Maciejewski TM, Szukiewicz D (2019) Current progress in the inflammatory background of angiogenesis in gynecological cancers. Inflamm Res 68(4):247–260. https://doi.org/10.1007/s00011-019-01215-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Karan D (2018) Inflammasomes: emerging central players in cancer immunology and immunotherapy. Front Immunol 9:3028. https://doi.org/10.3389/fimmu.2018.03028

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Dong T, Santos S, Yang Z, Yang S, Kirkhus NE (2020) Sputum and salivary protein biomarkers and point-of-care biosensors for the management of COPD. Analyst 145(5):1583–1604. https://doi.org/10.1039/c9an01704f

    Article  CAS  PubMed  Google Scholar 

  22. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4(1):71–78. https://doi.org/10.1038/nrc1256

    Article  CAS  PubMed  Google Scholar 

  23. Krishnan V, Schaar B, Tallapragada S, Dorigo O (2018) Tumor associated macrophages in gynecologic cancers. Gynecol Oncol 149(1):205–213. https://doi.org/10.1016/j.ygyno.2018.01.014

    Article  CAS  PubMed  Google Scholar 

  24. Szymanska-Chabowska A, Juzwiszyn J, Jankowska-Polanska B, Tanski W, Chabowski M (2020) Chitinase 3-like 1, nestin, and testin proteins as novel biomarkers of potential clinical use in colorectal cancer: a review. Adv Exp Med Biol. https://doi.org/10.1007/5584_2020_506

    Article  PubMed  Google Scholar 

Download references

Funding

The study was funded by the National Natural Science Foundation of China (No.81360388) and Guangxi Natural Science Foundation (No.2016 GXNSFAA380258).

Author information

Authors and Affiliations

  1. The First Affiliated Hospital of Guangxi Medical University, Nanning, China

    Qin Luo & Jiangtao Fan

  2. The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China

    Lili Li

Authors
  1. Qin Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jiangtao Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lili Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All the authors have read the manuscript and agreed to its being submitted for publication. All listed authors meet the appropriate authorship criteria. Nobody who qualifies for authorship has been omitted from the list. All authors have approved the acknowledgment of their contribution. LQ experimental operation, data collection or management, data analysis, manuscript writing/editing. FJT protocol development, data analysis. LL conceived the study, protocol development.

Corresponding author

Correspondence to Jiangtao Fan.

Ethics declarations

Conflict of interest

The authors have no conflict of interest or financial interest in any commercial companies pertaining to this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, Q., Fan, J. & Li, L. Silencing YKL-40 gene can inhibit inflammatory factor expression and affects the effect of THP-1 cells on endometrial cancer. Arch Gynecol Obstet 305, 467–473 (2022). https://doi.org/10.1007/s00404-021-06194-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-021-06194-5

Keywords

Search

Navigation